{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:24:02Z","timestamp":1783009442197,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.euros.2026.05.015","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:24:00Z","timestamp":1781155440000},"page":"72-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term Outcomes in Men with Stable PSA During 5-\u03b1 Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-1629","authenticated-orcid":false,"given":"Eugenio","family":"Ventimiglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Westerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andri Wilberg","family":"Orasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Ahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Gedeborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.05.015_b0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-5347(05)64051-7","article-title":"Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study","volume":"169","author":"Presti","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cncr.33875","article-title":"Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: a prospective evaluation of the PLUM cohort","volume":"128","author":"Patel","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2026.05.015_b0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eururo.2009.10.031","article-title":"Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies","volume":"57","author":"Schr\u00f6der","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/bju.16641","article-title":"Association of prostate\u2010specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result","volume":"135","author":"Pylv\u00e4l\u00e4inen","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.05.015_b0025","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0022-5347(05)00984-5","article-title":"Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5\u03b1-reductase inhibitor dutasteride","volume":"175","author":"Andriole","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.juro.2006.04.024","article-title":"The interpretation of serum prostate specific antigen in men receiving 5\u03b1-reductase inhibitors: a review and clinical recommendations","volume":"176","author":"Marks","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/ije\/dys068","article-title":"Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data base Sweden 2.0","volume":"42","author":"Van Hemelrijck","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.euros.2026.05.015_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2340\/sju.v60.43809","article-title":"Swedish regional population-based organised prostate cancer testing: why, what and how?","volume":"60","author":"Bratt","year":"2025","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2340\/sju.v60.43810","article-title":"A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer","volume":"60","author":"Ventimiglia","year":"2025","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2340\/sju.v61.45401","article-title":"Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer","volume":"61","author":"Ventimiglia","year":"2026","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euros.2026.05.015_b0060","unstructured":"Greenland S, Rothman KJ, Lash TL. Measures of effect and measures of association; 2008. https:\/\/www.researchgate.net\/publication\/285310332_Measures_of_effect_and_measures_of_association_Chapter_4 (accessed XXX)."},{"key":"10.1016\/j.euros.2026.05.015_b0065","unstructured":"The Board of Wealth and Welfare; n.d., https:\/\/www.socialstyrelsen.se\/en\/ (accessed March 27, 2025)."},{"key":"10.1016\/j.euros.2026.05.015_b0070","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djq265","article-title":"Effects of prostate-specific antigen testing on familial prostate cancer risk estimates","volume":"102","author":"Bratt","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euros.2026.05.015_b0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2026.05.015_b0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3349\/ymj.2018.59.2.219","article-title":"Prostate-specific antigen kinetics following 5\u03b1-reductase inhibitor treatment may be a useful indicator for repeat prostate biopsy","volume":"59","author":"Heo","year":"2018","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.euros.2026.05.015_b0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2340\/sju.v59.42272","article-title":"How to improve cancer care by use of guidelines and quality registers","volume":"59","author":"Stattin","year":"2024","journal-title":"Scand J Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832600515X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832600515X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:08:01Z","timestamp":1783008481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616832600515X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":17,"alternative-id":["S266616832600515X"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.015","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Outcomes in Men with Stable PSA During 5-\u03b1 Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}